Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Antitrust inquiry

- PMLiVE

Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn

About ten million people worldwide are affected by inflammatory bowel disease

- PMLiVE

US Supreme Court asked to block Purdue Pharma bankruptcy settlement

The company has been blamed for fuelling the opioid crisis with the promotion of its drug OxyContin

Biogen Idec building

Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit

For pursuing the case, the former employee will receive about $250m

- PMLiVE

AbbVie’s Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits

Together with Teva Pharmaceutical’s proposed $4.25bn deal, the total settlement deal could be worth $6.6bn

- PMLiVE

Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits

The figure includes the supply of up to $1.2bn of Teva’s Narcan, a life-saving medication which can reverse an overdose from opioids

- PMLiVE

Purdue to pay over $8bn to settle opioid-related criminal claims

Claims relate to Purdue's involvement in fuelling the opioid addiction crisis

- PMLiVE

US charges Teva for generic drug price-fixing plot

Company maintains it has not committed any wrongdoing

Teva Pharma logo

Teva among generic drugmakers hoping to settle US antitrust probe

A number of companies are accused of colluding on drug prices

- PMLiVE

Teva names new CFO and bulks up its opioid liability fund

Opioid liability issue overshadowed the company's Q3 results

- PMLiVE

US turns spotlight on GSK bribery allegations

Department of Justice to investigate whether pharma giant contravened foreign corruption act

- PMLiVE

Boehringer pays $95m to settle illegal marketing claims

Former sales rep whistleblower receives $17m from US federal government

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links